Does vitamin B12 need folate for DNA synthesis and red blood cell maturation?

Vitamin B12 and folate function as essential, biochemically linked cofactors. Their metabolic synergy is critical for cellular replication, and clinical deficits can occur even when circulating B12 levels appear normal or elevated.

Biochemical pathways in DNA synthesis

• The methylfolate trap: Vitamin B12 is a required cofactor for methionine synthase, which converts 5-methyltetrahydrofolate (5-methyl-THF) to tetrahydrofolate (THF). In functional B12 deficiency, folate becomes trapped as 5-methyl-THF, depleting the THF pool required for dTMP and purine synthesis.
• Erythroid maturation arrest: Impaired DNA replication in rapidly dividing bone marrow erythroid precursors causes nucleocytoplasmic asynchrony. While RNA and protein synthesis continue, cell division stalls, leading to macrocytosis and megaloblastic anemia.

Cellular transport and functional deficiency

• Uptake defects: Active cellular B12 uptake requires cobalamin to bind transcobalamin II (TCN2), forming holotranscobalamin, which enters cells via the CD320 receptor.
• High serum, low tissue B12: Severe pathogenic mutations in TCN2 or CD320 block cellular entry. Cobalamin accumulates in extracellular plasma, resulting in normal or high serum B12 concentrations alongside profound intracellular starvation, marked by elevated methylmalonic acid (MMA) and homocysteine.
• Genetic variants: The common TCN2 rs1801198 (776C>G; Pro259Arg) variant reduces transcobalamin binding affinity and lowers circulating active holotranscobalamin, predisposing individuals to functional deficiency under marginal dietary conditions.

Bottom line

• Normal or elevated serum B12 does not rule out functional tissue deficiency. When cellular uptake pathways are impaired, clinicians must rely on functional markers like MMA, homocysteine, and holotranscobalamin rather than total serum B12 to accurately assess cellular cobalamin status.